Premium
Unexpectedly high prevalence of rare genetic disorders in kidney transplant recipients with an unknown causal nephropathy
Author(s) -
Quaglia Marco,
Musetti Claudio,
Ghiggeri Gian Marco,
Fogazzi Giovanni Battista,
Settanni Fabio,
Boldorini Renzo Luciano,
Lazzarich Elisa,
Airoldi Andrea,
Izzo Cristina,
Giordano Mara,
Stratta Piero
Publication year - 2014
Publication title -
clinical transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 76
eISSN - 1399-0012
pISSN - 0902-0063
DOI - 10.1111/ctr.12408
Subject(s) - medicine , nephropathy , focal segmental glomerulosclerosis , transplantation , population , kidney transplantation , kidney disease , rare disease , disease , gastroenterology , pediatrics , kidney , glomerulonephritis , endocrinology , diabetes mellitus , environmental health
Background Patients with a rare genetic disease may receive renal transplantation ( KT x) without a correct diagnosis of causal nephropathy and therefore develop unexpected and even severe complications. The aim of the study was to describe the cases of rare genetic disorders diagnosed after KT x, in order to draw clinical lessons for the transplant physician. Methods We retrospectively assessed all patients who had received a diagnosis of a rare genetic disorder after KT x. Results In our center, more than 30% (278/911) of kidney transplant ( KT x) recipients were diagnosed with a causal nephropathy: Prevalence of rare genetic disorders in this group was 4.32% (12/278), including 2,8‐dihydroxyadeninuria (2,8‐ DHA ) disease (n = 2), HNF ‐1B‐associated nephropathy (n = 2), UMOD ‐related nephropathy (n = 5), Fabry disease (n = 1), INF 2 focal segmental glomerulosclerosis (n = 1), and Senior‐Løken syndrome (n = 1). 2,8‐ DHA nephropathy relapsed in both patients causing an acute renal failure and jeopardizing the graft. Conclusions Kidney transplant recipients without a diagnosis of causal nephropathy appear to be a selected population in which rare genetic diseases might be more common than expected. As even a belated diagnosis after KT x can have a significant impact on graft and patient survival and on other family members, this possibility should be evaluated in KT x recipients without a known causal nephropathy.